ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991

In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?)

May 13, 1977

Patient Advocacy: NBCC Urges Funding For Treatment Of Women Screened In CDC Program

July 17, 1998

In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair

August 15, 1997

Carmona’s Term as Surgeon General Expires.

August 4, 2006

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990